Etomidate in the control of severe Cushing's syndrome by neuroendocrine carcinoma.
作者信息
Reza-Albarrán Alfredo Adolfo, Andino Ríos Gerson Geovany, Gómez Herrera Laura Gabriela
机构信息
Department of Endocrinology and Metabolism Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Vasco de Quiroga 15 Tlalpan, México City 14000 México.
出版信息
Clin Case Rep. 2018 Mar 12;6(5):851-854. doi: 10.1002/ccr3.1478. eCollection 2018 May.
Abstract
Etomidate is a very effective drug in severe Cushing's syndrome that is refractory to ketoconazol. Control of the serum cortisol levels in ectopic Cushing's syndrome can be obtained with infusion rates much lower than those used in anesthesia, without respiratory side effects.
摘要
Zotero 插件